➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
AstraZeneca
Moodys
McKinsey
Express Scripts

Last Updated: September 26, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FOSRENOL

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Fosrenol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00160121 ↗ Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease Completed Shire Phase 4 2005-01-01 The purpose of this study is to test how well lanthanum carbonate reduces the pre-dialysis level of serum phosphorus in subjects undergoing dialysis due to end stage renal disease and to determine the patient and physician's satisfaction.
NCT00234702 ↗ Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease Completed Shire Phase 2 2005-10-01 Chronic kidney disease (CKD) can result in a loss of ability to filter and excrete phosphate. The body's attempt to adjust to an increased level of phosphate in the blood can result in elevated levels of hormones and minerals resulting in serious clinical consequences. This study is being conducted to evaluate the safety and efficacy of lanthanum carbonate in lowering high levels of phosphorus in the blood in subjects with CKD Stages 3 and 4 compared to placebo.
NCT00441545 ↗ Head to Head Study Against Sevelamer Hydrochloride Completed Shire Phase 3 2007-02-01 To compare the efficacy of Fosrenol (Lanthanum carbonate) and sevelamer hydrochloride in the reduction of serum phosphorus levels from baseline.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Fosrenol

Condition Name

Condition Name for Fosrenol
Intervention Trials
Hyperphosphatemia 6
Chronic Kidney Disease 4
Kidney Failure, Chronic 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Fosrenol
Intervention Trials
Kidney Diseases 13
Renal Insufficiency, Chronic 12
Hyperphosphatemia 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Fosrenol

Trials by Country

Trials by Country for Fosrenol
Location Trials
United States 70
Germany 9
Australia 6
Japan 5
South Africa 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Fosrenol
Location Trials
California 8
Colorado 6
Tennessee 4
Florida 4
Virginia 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Fosrenol

Clinical Trial Phase

Clinical Trial Phase for Fosrenol
Clinical Trial Phase Trials
Phase 4 6
Phase 3 3
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Fosrenol
Clinical Trial Phase Trials
Completed 15
Recruiting 4
Unknown status 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Fosrenol

Sponsor Name

Sponsor Name for Fosrenol
Sponsor Trials
Shire 13
Bayer 4
Astellas Pharma Inc 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Fosrenol
Sponsor Trials
Industry 24
Other 9
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Harvard Business School
Johnson and Johnson
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.